Company intelligence / Profile preview

Biovel Life Sciences

Bengaluru, Karnataka, India

Ownership: Private
Development stage: Other

Overview

Biovel Life Sciences is an Indian biotechnology company based in Bengaluru that specializes in the development and manufacturing of vaccines and recombinant biologics. The company is known for its high-capacity biopharmaceutical manufacturing facility that produces commercial-grade vaccines for Hepatitis B and Haemophilus influenzae type b (Hib). In 2010, Biovel was acquired by Mylan (now Viatris), serving as a strategic entry point for the company into the global biologics and biosimilars market. The facility continues to support the production of essential vaccines and biosimilar products for international healthcare markets.

Therapeutic areas: HematologyInfectious Diseases
Modalities: VaccineRecombinant proteinBiologic
Industry: Biotech

Partnerships

Mylan

Beyond the preview

Go deeper on Biovel Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biovel Life Sciences.

Explore the full profile